MANDI BREYMAN: Open Payments
NPI 1003150368 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 34 payments from 13 companies in 2025. Trend: 2023 $822 · 2024 $655 · 2025 $949
Food & beverage: $896Education: $53
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $270 |
| Novo Nordisk Inc | 8 | $205 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Lilly USA, LLC | 2 | $52 |
| BioCryst US Sales Co., LLC | 1 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Ionis Pharmaceuticals, Inc. | 1 | $35 |
| Exact Sciences Corporation | 1 | $30 |
Products named: DUPIXENT, Wegovy, Rybelsus, TEZSPIRE, ORLADEYO, NUCALA, TALTZ, Cologuard Collection Kit.
Industry payments across HI — which companies pay providers there.
